Potential Gold Rush For Investors Sparked By USA Vs. China Trade War
Right now, China has the US Military in a stranglehold. They hold a monopoly on one of our most CRITICAL defense elements. But thanks to executive orders from both Biden and Trump...
China's Monopoly Is About To Crumble...

NGM Insider Trading

Insider Ownership Percentage: 38.10%
Insider Buying (Last 12 Months): $19,851,722.07
Insider Selling (Last 12 Months): $273,150.00

NGM Biopharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at NGM Biopharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NGM Biopharmaceuticals Share Price & Price History

Current Price: $5.51
Price Change: Price Decrease of -0.09 (-1.61%)
As of 12/6/2022 04:09 PM ET

This chart shows the closing price history over time for NGM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

NGM Biopharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/2022Group L P ColumnDirectorBuy35,997$5.00$179,985.00375,842View SEC Filing Icon  
11/3/2022Group L P ColumnDirectorBuy104,090$4.99$519,409.10304,787View SEC Filing Icon  
10/27/2022David V GoeddelDirectorBuy76,877$4.86$373,622.22200,697View SEC Filing Icon  
10/25/2022Group L P ColumnDirectorBuy51,046$4.75$242,468.5051,046View SEC Filing Icon  
10/17/2022David V GoeddelDirectorBuy50,000$3.18$159,000.00130,000View SEC Filing Icon  
6/9/2022Group L P ColumnDirectorBuy984,161$13.50$13,286,173.502,650,177View SEC Filing Icon  
6/2/2022Group L P ColumnDirectorBuy34,200$13.03$445,626.001,698,493View SEC Filing Icon  
5/31/2022Group L P ColumnDirectorBuy61,806$13.47$832,526.821,576,458View SEC Filing Icon  
5/26/2022Group L P ColumnDirectorBuy20,201$13.49$272,511.491,514,071View SEC Filing Icon  
5/24/2022Group L P ColumnDirectorBuy17,828$13.37$238,360.361,452,674View SEC Filing Icon  
5/19/2022Group L P ColumnDirectorBuy20,666$13.25$273,824.501,417,028View SEC Filing Icon  
5/17/2022Group L P ColumnDirectorBuy89,049$13.42$1,195,037.581,336,461View SEC Filing Icon  
5/11/2022Group L P ColumnDirectorBuy83,175$11.25$935,718.751,012,753View SEC Filing Icon  
5/9/2022Group L P ColumnDirectorBuy83,175$10.79$897,458.25902,090View SEC Filing Icon  
12/6/2021Jin-Long ChenInsiderSell15,000$18.21$273,150.00View SEC Filing Icon  
11/18/2021David J. WoodhouseCEOSell15,000$20.02$300,300.00View SEC Filing Icon  
11/15/2021Jin-Long ChenInsiderSell30,000$19.73$591,900.00View SEC Filing Icon  
10/11/2021Jin-Long ChenInsiderSell15,000$20.41$306,150.00View SEC Filing Icon  
10/5/2021Hsiao D. LieuSVPSell2,000$22.00$44,000.00View SEC Filing Icon  
9/13/2021Jin-Long ChenInsiderSell15,000$26.03$390,450.00View SEC Filing Icon  
8/9/2021Jin-Long ChenInsiderSell15,000$24.46$366,900.00View SEC Filing Icon  
4/12/2021Jin-Long ChenInsiderSell25,000$24.65$616,250.00945,005View SEC Filing Icon  
3/1/2021Jin-Long ChenInsiderSell25,000$26.66$666,500.00970,005View SEC Filing Icon  
1/4/2021Jin-Long ChenInsiderSell25,000$29.28$732,000.00870,375View SEC Filing Icon  
12/14/2020Jin-Long ChenInsiderSell25,000$28.01$700,250.00908,879View SEC Filing Icon  
10/12/2020Jin-Long ChenInsiderSell25,000$17.02$425,500.00945,005View SEC Filing Icon  
9/1/2020Group L P ColumnDirectorBuy36,494$17.64$643,754.16View SEC Filing Icon  
9/1/2020Jin-Long ChenInsiderSell25,000$17.83$445,750.00977,618View SEC Filing Icon  
8/27/2020Group L P ColumnDirectorBuy36,359$17.79$646,826.61View SEC Filing Icon  
8/24/2020Group L P ColumnDirectorBuy11,024$17.96$197,991.04View SEC Filing Icon  
8/21/2020Group L P ColumnDirectorBuy7,321$17.97$131,558.37View SEC Filing Icon  
8/17/2020Group L P ColumnDirectorBuy6,425$17.89$114,943.25View SEC Filing Icon  
8/13/2020Group L P ColumnDirectorBuy19,895$17.89$355,921.55View SEC Filing Icon  
7/30/2020Group L P ColumnDirectorBuy732$17.99$13,168.68View SEC Filing Icon  
7/27/2020Group L P ColumnDirectorBuy3,834$17.99$68,973.66View SEC Filing Icon  
7/24/2020Group L P ColumnDirectorBuy68,749$17.93$1,232,669.57View SEC Filing Icon  
7/22/2020Group L P ColumnDirectorBuy193$18.00$3,474.00View SEC Filing Icon  
7/1/2020Jin-Long ChenInsiderSell25,000$18.91$472,750.001,027,268View SEC Filing Icon  
6/15/2020Jin-Long ChenInsiderSell25,000$21.65$541,250.00View SEC Filing Icon  
5/15/2020Hsiao D. LieuSVPSell1,562$22.00$34,364.00View SEC Filing Icon  
4/7/2020Group L P ColumnMajor ShareholderBuy138,315$14.19$1,962,689.85View SEC Filing Icon  
4/7/2020Peter SvennilsonDirectorBuy123,728$14.38$1,779,208.6420,000View SEC Filing Icon  
4/2/2020Group L P ColumnMajor ShareholderBuy250,984$12.78$3,207,575.52View SEC Filing Icon  
4/2/2020Peter SvennilsonDirectorBuy14,850$12.40$184,140.0020,000View SEC Filing Icon  
3/31/2020Peter SvennilsonDirectorBuy118,067$12.53$1,479,379.5120,000View SEC Filing Icon  
3/25/2020Group L P ColumnMajor ShareholderBuy301,180$13.33$4,014,729.40View SEC Filing Icon  
3/25/2020Peter SvennilsonDirectorBuy2,416$12.49$30,175.8420,000View SEC Filing Icon  
3/23/2020Peter SvennilsonDirectorBuy170,387$11.63$1,981,600.8120,000View SEC Filing Icon  
3/20/2020Group L P ColumnMajor ShareholderBuy143,082$11.77$1,684,075.14View SEC Filing Icon  
3/19/2020Peter SvennilsonDirectorBuy148,464$11.59$1,720,697.7620,000View SEC Filing Icon  
3/5/2020Peter SvennilsonDirectorBuy8,307$18.00$149,526.0020,000View SEC Filing Icon  
3/4/2020Group L P ColumnMajor ShareholderBuy9,986$17.96$179,348.56View SEC Filing Icon  
3/3/2020Peter SvennilsonDirectorBuy38,758$17.99$697,256.4220,000View SEC Filing Icon  
3/2/2020Group L P ColumnMajor ShareholderBuy14,124$17.90$252,819.60View SEC Filing Icon  
2/28/2020Group L P ColumnMajor ShareholderBuy75,447$18.04$1,361,063.88View SEC Filing Icon  
2/27/2020Peter SvennilsonDirectorBuy33,896$17.91$607,077.3620,000View SEC Filing Icon  
2/26/2020Group L P ColumnMajor ShareholderBuy3,751$18.00$67,518.00View SEC Filing Icon  
2/6/2020Group L P ColumnMajor ShareholderBuy44,900$15.47$694,603.00View SEC Filing Icon  
1/9/2020Jin-Long ChenInsiderSell18,641$17.95$334,605.951,012,783View SEC Filing Icon  
1/7/2020Jin-Long ChenInsiderSell16,090$18.20$292,838.001,012,783View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for NGM Biopharmaceuticals (NASDAQ:NGM)

85.05% of NGM Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NGM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

NGM Biopharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2022BNP Paribas Arbitrage SNC17,092$0.22M0.0%+13.4%0.021%Search for SEC Filing on Google Icon
11/15/2022State Street Corp855,575$11.19M0.0%+11.0%1.047%Search for SEC Filing on Google Icon
11/15/2022Jacobs Levy Equity Management Inc.68,649$0.90M0.0%N/A0.084%Search for SEC Filing on Google Icon
11/15/2022Algert Global LLC77,840$1.02M0.1%+8.2%0.095%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP286,700$3.75M0.0%+45.5%0.351%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP259,940$3.40M0.0%+53.9%0.318%Search for SEC Filing on Google Icon
11/15/2022Trexquant Investment LP35,245$0.46M0.0%N/A0.043%Search for SEC Filing on Google Icon
11/15/2022UBS Asset Management Americas Inc.30,767$0.40M0.0%-11.2%0.038%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.3,899,297$51M0.0%+14.6%4.771%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD33,945$0.45M0.0%+66.1%0.042%Search for SEC Filing on Google Icon
11/15/2022Logos Global Management LP850,000$11.12M1.4%N/A1.040%Search for SEC Filing on Google Icon
11/15/2022First Light Asset Management LLC955,505$12.50M1.3%-15.9%1.169%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp150,629$1.97M0.0%+15.2%0.184%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.4,066,577$53.19M0.0%+5.0%4.976%Search for SEC Filing on Google Icon
11/14/2022Royal Bank of Canada3,195$41K0.0%+353.2%0.004%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.362,900$4.75M0.0%-72.5%0.444%Search for SEC Filing on Google Icon
11/14/2022Cubist Systematic Strategies LLC74,998$0.98M0.0%-58.8%0.092%Search for SEC Filing on Google Icon
11/14/2022PDT Partners LLC34,267$0.45M0.1%N/A0.042%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC274,200$3.59M0.0%-19.0%0.336%Search for SEC Filing on Google Icon
11/14/2022Nuveen Asset Management LLC738,810$9.66M0.0%+38.0%0.904%Search for SEC Filing on Google Icon
11/14/2022Parkwood LLC44,314$0.58M0.1%N/A0.054%Search for SEC Filing on Google Icon
11/14/2022AXA S.A.405,683$5.31M0.0%+0.8%0.496%Search for SEC Filing on Google Icon
11/14/2022Rubric Capital Management LP877,161$11.47M0.6%+10.0%1.073%Search for SEC Filing on Google Icon
11/14/2022Hsbc Holdings PLC12,757$0.17M0.0%+23.6%0.016%Search for SEC Filing on Google Icon
11/14/2022Hennion & Walsh Asset Management Inc.175,183$2.29M0.2%+3.5%0.214%Search for SEC Filing on Google Icon
11/10/2022Connor Clark & Lunn Investment Management Ltd.110,699$1.45M0.0%+207.0%0.135%Search for SEC Filing on Google Icon
11/10/2022ExodusPoint Capital Management LP52,672$0.69M0.0%N/A0.064%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP787,808$10.30M0.0%+21.8%0.964%Search for SEC Filing on Google Icon
11/10/2022Tower Research Capital LLC TRC 5,674$74K0.0%+154.1%0.007%Search for SEC Filing on Google Icon
11/8/2022New York State Common Retirement Fund26,462$0.35M0.0%+16.5%0.033%Search for SEC Filing on Google Icon
11/7/2022Jump Financial LLC31,400$0.41M0.0%+9.8%0.039%Search for SEC Filing on Google Icon
11/4/2022Russell Investments Group Ltd.24,332$0.32M0.0%+94.7%0.030%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC43,895$0.58M0.0%+72.6%0.055%Search for SEC Filing on Google Icon
11/2/2022Los Angeles Capital Management LLC11,919$0.16M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/1/2022Jennison Associates LLC122,430$1.60M0.0%N/A0.152%Search for SEC Filing on Google Icon
10/28/2022Silverarc Capital Management LLC94,517$1.24M0.4%+7.0%0.118%Search for SEC Filing on Google Icon
10/27/2022Strs Ohio45,100$0.59M0.0%-4.4%0.056%Search for SEC Filing on Google Icon
10/25/2022Raymond James & Associates95,686$1.25M0.0%+34.8%0.119%Search for SEC Filing on Google Icon
10/25/2022Raymond James Financial Services Advisors Inc.84,886$1.11M0.0%+35.4%0.106%Search for SEC Filing on Google Icon
9/2/2022Amundi7,407$0.12M0.0%N/A0.009%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.172,206$2.21M0.0%+5.1%0.214%Search for SEC Filing on Google Icon
8/16/2022Woodline Partners LP134,188$1.72M0.0%-71.5%0.167%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD20,440$0.26M0.0%+7.5%0.025%Search for SEC Filing on Google Icon
8/15/2022State Street Corp770,442$9.88M0.0%+11.4%0.959%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC181,986$2.33M0.0%+124.2%0.226%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.1,320,662$16.93M0.1%-58.9%1.643%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC441,475$5.66M0.0%+5.8%0.549%Search for SEC Filing on Google Icon
8/15/2022Partners Group Holding AG177,255$2.27M0.1%N/A0.221%Search for SEC Filing on Google Icon
8/15/2022UBS Asset Management Americas Inc.34,663$0.44M0.0%+86.1%0.043%Search for SEC Filing on Google Icon
8/13/2022Quantbot Technologies LP5,932$76K0.0%+315.7%0.007%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC338,368$4.34M0.0%+117.3%0.421%Search for SEC Filing on Google Icon
8/13/2022American International Group Inc.18,351$0.24M0.0%+17.3%0.023%Search for SEC Filing on Google Icon
8/13/2022Column Group LLC18,136,735$232.51M49.5%+11.6%22.568%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp341,251$4.38M0.0%+16.4%0.425%Search for SEC Filing on Google Icon
8/12/2022First Light Asset Management LLC1,135,884$14.56M1.7%+39.1%1.413%Search for SEC Filing on Google Icon
8/12/2022Lexington Partners L.P.110,428$1.42M0.7%N/A0.137%Search for SEC Filing on Google Icon
8/12/2022Credit Suisse AG27,515$0.35M0.0%+12.1%0.034%Search for SEC Filing on Google Icon
8/12/2022Fox Run Management L.L.C.11,128$0.14M0.1%N/A0.014%Search for SEC Filing on Google Icon
8/12/2022FMR LLC2,060,533$26.42M0.0%+61.8%2.564%Search for SEC Filing on Google Icon
8/12/2022BNP Paribas Arbitrage SA15,078$0.19M0.0%-31.5%0.019%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers49,917$0.64M0.0%+25.4%0.062%Search for SEC Filing on Google Icon
8/11/2022Deutsche Bank AG263,912$3.38M0.0%+53.5%0.328%Search for SEC Filing on Google Icon
8/11/2022Washington University44,314$0.57M0.2%N/A0.055%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.552,541$7.08M0.0%+3.5%0.687%Search for SEC Filing on Google Icon
8/10/2022Principal Financial Group Inc.13,190$0.17M0.0%N/A0.016%Search for SEC Filing on Google Icon
8/9/2022Swiss National Bank64,000$0.82M0.0%-12.9%0.080%Search for SEC Filing on Google Icon
8/5/2022State Board of Administration of Florida Retirement System15,654$0.20M0.0%N/A0.020%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.36,053$0.46M0.0%N/A0.045%Search for SEC Filing on Google Icon
8/4/2022Steward Partners Investment Advisory LLC4,817$62K0.0%+138.8%0.006%Search for SEC Filing on Google Icon
8/1/2022ProShare Advisors LLC10,576$0.14M0.0%-24.2%0.013%Search for SEC Filing on Google Icon
7/29/2022SG Americas Securities LLC11,719$0.15M0.0%-79.9%0.015%Search for SEC Filing on Google Icon
7/29/2022Russell Investments Group Ltd.12,500$0.16M0.0%-22.8%0.016%Search for SEC Filing on Google Icon
7/28/2022Hamilton Lane Advisors LLC37,503$0.48M0.2%N/A0.047%Search for SEC Filing on Google Icon
7/26/2022Mirae Asset Global Investments Co. Ltd.10,974$0.14M0.0%N/A0.014%Search for SEC Filing on Google Icon
7/25/2022Silverarc Capital Management LLC88,303$1.13M0.3%-56.0%0.111%Search for SEC Filing on Google Icon
7/25/2022Strs Ohio47,200$0.61M0.0%+5.1%0.060%Search for SEC Filing on Google Icon
7/19/2022Hennion & Walsh Asset Management Inc.169,337$2.17M0.1%-31.3%0.214%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank3,933$60K0.0%N/A0.005%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE40,782$0.62M0.0%-11.3%0.051%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA22,012$0.34M0.0%-17.8%0.028%Search for SEC Filing on Google Icon
5/17/2022Point72 Hong Kong Ltd2,034$31K0.0%+102.8%0.003%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada2,314$36K0.0%-59.3%0.003%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System40,107$0.61M0.0%-7.0%0.051%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.163,918$2.50M0.0%-20.7%0.207%Search for SEC Filing on Google Icon
5/16/2022PDT Partners LLC38,179$0.58M0.1%-33.7%0.048%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP471,039$7.18M0.1%N/A0.594%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP27,005$0.41M0.0%-4.2%0.034%Search for SEC Filing on Google Icon
5/16/2022State Street Corp691,506$10.55M0.0%+2.4%0.872%Search for SEC Filing on Google Icon
5/16/2022Engineers Gate Manager LP40,613$0.62M0.0%-3.8%0.051%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.55,238$0.84M0.0%+6.4%0.070%Search for SEC Filing on Google Icon
5/13/2022Silverarc Capital Management LLC200,494$3.06M1.3%N/A0.253%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC155,700$2.37M0.0%+108.4%0.196%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp293,106$4.47M0.0%-3.7%0.370%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.299,547$4.57M0.0%+6.8%0.378%Search for SEC Filing on Google Icon
5/13/2022First Light Asset Management LLC816,653$12.45M1.1%+43.0%1.030%Search for SEC Filing on Google Icon
5/13/2022Jasper Ridge Partners L.P.311,250$4.75M0.2%+0.3%0.393%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.15,643$0.24M0.0%-6.6%0.020%Search for SEC Filing on Google Icon
5/13/2022Candriam Luxembourg S.C.A.217,187$3.31M0.0%N/A0.274%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.3,014,475$45.97M0.0%+1.6%3.803%Search for SEC Filing on Google Icon
5/13/2022Allianz Asset Management GmbH48,070$0.73M0.0%N/A0.061%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
NGM Biopharmaceuticals logo
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trials for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an antagonist antibody that binds GFRAL that is in Phase I/II clinical trials; NGM621, an immunoglobulin 1 monoclonal antibody in Phase II clinical trials for the treatment of geographic atrophy; NGM707, an immunoglobulin-like transcript 2/ immunoglobulin-like transcript 4 dual antagonist monoclonal antibody that is in Phase I/II clinical trials for the treatment of patients with advanced solid tumors; and NGM831 and NGM438 for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp.; and a collaboration agreement with Merck & Co., Inc. to focus primarily on the development of novel medicines for unmet patient needs in retinal and CVM diseases, including heart failure. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.
Read More on NGM Biopharmaceuticals

Today's Range

Now: $5.51
Low: $5.43
High: $5.68

50 Day Range

MA: $7.19
Low: $3.41
High: $13.10

52 Week Range

Now: $5.51
Low: $2.92
High: $19.14

Volume

13,156 shs

Average Volume

460,116 shs

Market Capitalization

$450.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of NGM Biopharmaceuticals?

NGM Biopharmaceuticals' top insider shareholders include:
  1. Group L P Column (Director)
  2. Jin-Long Chen (Insider)
  3. David V Goeddel (Director)
  4. David J Woodhouse (CEO)
  5. Hsiao D Lieu (SVP)
Learn More about top insider investors at NGM Biopharmaceuticals.

Who are the major institutional investors of NGM Biopharmaceuticals?

NGM Biopharmaceuticals' top institutional shareholders include:
  1. BlackRock Inc. — 4.98%
  2. Vanguard Group Inc. — 4.77%
  3. First Light Asset Management LLC — 1.17%
  4. Rubric Capital Management LP — 1.07%
  5. State Street Corp — 1.05%
  6. Logos Global Management LP — 1.04%
Learn More about top institutional investors of NGM Biopharmaceuticals stock.

Which major investors are selling NGM Biopharmaceuticals stock?

During the last quarter, NGM stock was sold by these institutional investors:
  1. Point72 Asset Management L.P.
  2. First Light Asset Management LLC
  3. Cubist Systematic Strategies LLC
  4. Renaissance Technologies LLC
  5. UBS Asset Management Americas Inc.
  6. Strs Ohio

Which major investors are buying NGM Biopharmaceuticals stock?

During the last quarter, NGM stock was acquired by institutional investors including:
  1. Logos Global Management LP
  2. Vanguard Group Inc.
  3. Nuveen Asset Management LLC
  4. BlackRock Inc.
  5. Dimensional Fund Advisors LP
  6. Jennison Associates LLC
  7. Two Sigma Investments LP
  8. Two Sigma Advisers LP
Within the last year, these company insiders have bought NGM Biopharmaceuticals stock:
  1. Group L P Column (Director)
  2. Jin-Long Chen (Insider)
Learn More investors buying NGM Biopharmaceuticals stock.
The New Energy Crisis No One Saw Coming
Free investor report reveals how the electric car initiative is putting the U.S. in peril...and shows how to potentially capitalize on this crisis with a junior mining company.
See how this new energy crisis could create a boom